What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives

被引:1
|
作者
Alfieri, Carlo Maria [1 ,2 ]
Molinari, Paolo [1 ,3 ]
Cinque, Felice [4 ,5 ]
Vettoretti, Simone [1 ]
Cespiati, Annalisa [4 ,5 ]
Bignamini, Daniela [4 ]
Nardelli, Luca [1 ,2 ]
Fracanzani, Anna Ludovica [4 ,5 ]
Castellano, Giuseppe [1 ,2 ]
Lombardi, Rosa [4 ,5 ]
机构
[1] Fdn IRCCS CaGranda Osped Policlin, Dept Nephrol Dial & Renal Transplantat, I-20122 Milan, Italy
[2] Univ Milan, Dept Clin Sci & Community Hlth, I-20122 Milan, Italy
[3] Univ Milan, Postgrad Sch Specializat Nephrol, I-20122 Milan, Italy
[4] Fdn IRCCS CaGranda Osped Maggiore Policlin Milano, SC Med Indirizzo Metab, I-20122 Milan, Italy
[5] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
关键词
chronic kidney disease; diabetic kidney disease; metabolic dysfunction-associated steatotic liver disease; liver fibrosis; hyperfiltration; FATTY LIVER-DISEASE; CHRONIC KIDNEY-DISEASE; CONTROLLED-TRIAL; WEIGHT-LOSS; EPIDEMIOLOGY; SUSCEPTIBILITY; PREVALENCE; FEATURES; UPDATE; NAFLD;
D O I
10.3390/ijms25147728
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes mellitus (DM) significantly impacts renal and hepatic function, necessitating comprehensive understanding and management strategies. Renal involvement, namely diabetic kidney disease (DKD), presents a global challenge, with increasing prevalence paralleling DM rates. Lifestyle modifications and pharmacotherapy targeting hypertension and glycemic control have pivotal roles in DKD management. Concurrently, hepatic involvement in DM, characterized by metabolic dysfunction-associated steatotic liver disease (MASLD), presents a bidirectional relationship. DM exacerbates MASLD progression, while MASLD predisposes to DM development and worsens glycemic control. Screening for MASLD in DM patients is of high importance, utilizing non-invasive methods like ultrasound and fibrosis scores. Lifestyle modifications, such as weight loss and a Mediterranean diet, mitigate MASLD progression. Promising pharmacotherapies, like SGLT2 inhibitors and GLP-1 agonists, demonstrate efficacy in both DM and MASLD management. Special populations, such as diabetic individuals undergoing hemodialysis or kidney transplant recipients, demand special care due to unique clinical features. Similarly, DM exacerbates complications in MASLD patients, elevating the risks of hepatic decompensation and hepatocellular carcinoma. Recognizing the interconnectedness of DM, renal, and hepatic diseases underscores the need for multidisciplinary approaches for optimal patient outcomes. The present review aims to present the main characteristics and crucial points not to be overlooked regarding the renal and hepatic involvement in DM patients focusing on the inter-relationships between the renal and the hepatic involvements.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Management of Obesity in Patients with Type 2 Diabetes Mellitus
    Gagliardi, Lucia
    Witterti, Gary
    CURRENT DIABETES REVIEWS, 2007, 3 (02) : 95 - 101
  • [2] Management of hospitalized patients with type 2 diabetes mellitus
    Lilley, SH
    Levine, GI
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (05) : 1079 - 1088
  • [3] Management of hospitalized type 2 diabetes mellitus patients
    Jose Marin-Penalver, Juan
    Martin-Timon, Iciar
    Javier del Canizo-Gomez, Francisco
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2016, 4 (04) : 155 - 161
  • [4] Management of hypertension in patients with type 2 diabetes mellitus
    Mashitisho, M. L., I
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (01) : 41 - 44
  • [5] What patients with diabetes mellitus type 2 know on their disease
    Vicente Sanchez, Belkis M.
    Zerquera Trujillo, Gisela
    Rivas Alpizar, Elodia M.
    Munoz Cocina, Jose A.
    Gutierrez Quintero, Yaremy Teresita
    Castaneda Alvarez, Eduardo
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2010, 8 (06): : 412 - 418
  • [6] Perspectives of the Use of Fenofibrate in Patients With Type 2 Diabetes Mellitus: What is New After the ACCORD Study?
    Susekov, A. V.
    Hohlova, N. V.
    KARDIOLOGIYA, 2011, 51 (09) : 68 - 74
  • [7] Management of diabetes mellitus type-2 in the geriatric population: Current perspectives
    Bajwa, Sukhminder Jit Singh
    Sehgal, Vishal
    Kalra, Sanjay
    Baruah, Manash Pratim
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2014, 6 (03): : 151 - 157
  • [8] The role of weight control in the management of type 2 diabetes mellitus: Perspectives on semaglutide
    Kurtzhals, Peter
    Kreiner, Frederik Flindt
    Singh, Rubdeep
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 203
  • [9] Blood pressure management in patients with type 2 diabetes mellitus
    Hisashi Kai
    Hypertension Research, 2017, 40 : 721 - 729
  • [10] PHARMACOLOGICAL MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CKD
    Hamilton, Catherine A.
    JOURNAL OF RENAL CARE, 2012, 38 : 59 - 66